Skip to main content
. 2022 Aug 31;40(40):5798–5805. doi: 10.1016/j.vaccine.2022.08.036

Table 4.

Serious AESIs, Moderna trial.

Brighton category Vaccine Placebo Vaccine events per 10,000 Placebo events per 10,000 Difference in events per 10,000 Risk ratio
Association with specific vaccine platform(s)
Bell's Palsy 1 0 0.7 0.0 0.7 N/A
Encephalitis/encephalomyelitis 1 0 0.7 0.0 0.7 N/A
Seen with COVID-19
Acute kidney injury 1 3 0.7 2.0 −1.3 0.33
Acute liver injury 1 0 0.7 0.0 0.7 N/A
Acute respiratory distress syndrome 7 4 4.6 2.6 2.0 1.75
Angioedema 0 2 0.0 1.3 −1.3 0.00
Coagulation disorder 20 13 13.2 8.6 4.6 1.54
Generalized Convulsions 2 0 1.3 0.0 1.3 N/A
Myelitis 0 1 0.0 0.7 −0.7 0.00
Myocarditis/pericarditis 4 5 2.6 3.3 −0.7 0.80
Other forms of acute cardiac injury 26 26 17.1 17.1 0.0 1.00
Other rash 1 1 0.7 0.7 0.0 1.00
Rhabdomyolysis 0 1 0.0 0.7 −0.7 0.00
Single Organ Cutaneous Vasculitis 1 0 0.7 0.0 0.7 N/A
Subtotal 65 56 42.8 36.9 5.9 1.16
Brighton list of 29 clinical diagnoses seen with COVID-19
Abscess 1 0 0.7 0.0 0.7 N/A
Arthritis 3 1 2.0 0.7 1.3 3.00
Cholecystitis 4 0 2.6 0.0 2.6 N/A
Colitis/Enteritis 6 3 4.0 2.0 2.0 2.00
Diarrhea 2 1 1.3 0.7 0.7 2.00
Hyperglycemia 1 0 0.7 0.0 0.7 N/A
Hyponatremia 1 1 0.7 0.7 0.0 1.00
Pancreatitis 2 0 1.3 0.0 1.3 N/A
Pneumothorax 0 1 0.0 0.7 −0.7 0.00
Psychosis 1 1 0.7 0.7 0.0 1.00
Thyroiditis 1 0 0.7 0.0 0.7 N/A
Subtotal 22 8 14.5 5.3 9.2 2.75
Total 87 64 57.3 42.2 15.1 1.36